Recruiting Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) NCT04728893 Conditions Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more Locations Highlands Oncology Group ( Site 2728) — Springdale, Arkansas, United States University of California San Diego Moores Cancer Center ( Site 2717) — La Jolla, California, United States Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) — Torrance, California, United States Colorado Blood Cancer Institute ( Site 2726) — Denver, Colorado, United States View all 121 locations View more locations Show fewer locations Loading locations... View Trial Details
